Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs
- 7 November 2006
- Vol. 25 (8), 1398-1408
- https://doi.org/10.1016/j.vaccine.2006.10.046
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239Journal of Virology, 2006
- Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged MonkeysScience, 2006
- Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primatesThe Journal of Experimental Medicine, 2006
- Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersVaccine, 2006
- Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1Journal of Virology, 2005
- Replication-Defective Adenovirus Serotype 5 Vectors Elicit Durable Cellular and Humoral Immune Responses in Nonhuman PrimatesJournal of Virology, 2005
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Polyvalent Envelope Glycoprotein Vaccine Elicits a Broader Neutralizing Antibody Response but Is Unable To Provide Sterilizing Protection against Heterologous Simian/Human Immunodeficiency Virus Infection in Pigtailed MacaquesJournal of Virology, 2001
- Interactions of Polyclonal and Monoclonal Anti-Glycoprotein 120 Antibodies with Oligomeric Glycoprotein 120-Glycoprotein 41 Complexes of a Primary HIV Type 1 Isolate: Relationship to NeutralizationAIDS Research and Human Retroviruses, 1998
- Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160Journal of Clinical Immunology, 1992